Characterization of dual PTEN and p53-targeting microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic locus

Cell Reports

Volumn 8, Issue 3, 2014, Pages 714-722

  Tay, Yvonne ^a   Tan, Shen Mynn ^a,b   Karreth, Florian A ^a,c   Lieberman, Judy ^a,b   Pandolfi, Pier Paolo ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; MICRORNA; MICRORNA 518C; MICRORNA 638; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG; DYNAMIN II; MIRN518 MICRORNA, HUMAN; MIRN638 MICRORNA, HUMAN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DNM2 GENE; GENE IDENTIFICATION; GENE LOCUS; GENE OVEREXPRESSION; ONCOGENE; PRIORITY JOURNAL; PROTEIN TARGETING; UPREGULATION; ANIMAL; GENETICS; HCT116 CELL LINE; HUMAN; METABOLISM; MOUSE;

ANIMALS; BRCA1 PROTEIN; CARCINOGENESIS; DYNAMIN II; HCT116 CELLS; HUMANS; MICE; MICRORNAS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84924633328     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.06.064     Document Type: Article

References (41)

1. Abou-Kheir, W., Hynes, P.G., Martin, P., Yin, J.J., Liu, Y.N., Seng, V., Lake, R., Spurrier, J., and Kelly, K. (2011). Self-renewing Pten-/-TP53-/-protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. PLoS One 6, e26112.
2. Altiok, S., Batt, D., Altiok, N., Papautsky, A., Downward, J., Roberts, T.M., and Avraham, H. (1999). Heregulin induces phosphorylation of BRCA1 through phosphatidylinositol 3-Kinase/AKT in breast cancer cells. J. Biol. Chem. 274, 32274-32278.
3. Andjelkovic, T., Bankovic, J., Stojsic, J., Milinkovic, V., Podolski-Renic, A., Ruzdijic, S., and Tanic, N. (2011). Coalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patients. Transl. Res. 157, 19-28.
4. Bartel, D.P., and Chen, C.Z. (2004). Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 5, 396-400.
5. Berger, A.H., Knudson, A.G., and Pandolfi, P.P. (2011). A continuum model for tumour suppression. Nature 476, 163-169.
6. Bortolin-Cavaillé, M.L., Dance, M., Weber, M., and Cavaillé, J. (2009). C19MC microRNAs are processed from introns of large Pol-II, non-protein-coding transcripts. Nucleic Acids Res. 37, 3464-3473.
7. Chen, Z., Trotman, L.C., Shaffer, D., Lin, H.K., Dotan, Z.A., Niki, M., Koutcher, J.A., Scher, H.I., Ludwig, T., Gerald, W., et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730.
8. Di Cristofano, A., Pesce, B., Cordon-Cardo, C., and Pandolfi, P.P. (1998). Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355.
9. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221.
10. Dyrskjøt, L., Ostenfeld, M.S., Bramsen, J.B., Silahtaroglu, A.N., Lamy, P., Ramanathan, R., Fristrup, N., Jensen, J.L., Andersen, C.L., Zieger, K., et al. (2009). Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 69, 4851-4860.
11. Eppinga, R.D., Krueger, E.W., Weller, S.G., Zhang, L., Cao, H., and McNiven, M.A. (2012). Increased expression of the large GTPase dynamin 2 potentiates metastatic migration and invasion of pancreatic ductal carcinoma. Oncogene 31, 1228-1241.
12. Feng, H., Liu, K.W., Guo, P., Zhang, P., Cheng, T., McNiven, M.A., Johnson, G.R., Hu, B., and Cheng, S.Y. (2012). Dynamin 2 mediates PDGFRa-SHP-2-promoted glioblastoma growth and invasion. Oncogene 31, 2691-2702.
13. Freeman, D.J., Li, A.G., Wei, G., Li, H.H., Kertesz, N., Lesche, R., Whale, A.D., Martinez-Diaz, H., Rozengurt, N., Cardiff, R.D., et al. (2003). PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and-independent mechanisms. Cancer Cell 3, 117-130.
14. Hermeking, H. (2012). MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 12, 613-626.
15. Isaacs, W.B., Carter, B.S., and Ewing, C.M. (1991). Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 51, 4716-4720.
16. Jaiswal, R., Luk, F., Gong, J., Mathys, J.M., Grau, G.E., and Bebawy, M. (2012). Microparticle conferred microRNA profiles-implications in the transfer and dominance of cancer traits. Mol. Cancer 11, 37.
17. Lal, A., Thomas, M.P., Altschuler, G., Navarro, F., O'Day, E., Li, X.L., Concepcion, C., Han, Y.C., Thiery, J., Rajani, D.K., et al. (2011). Capture of microRNAbound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet. 7, e1002363.
18. Landi, M.T., Zhao, Y., Rotunno, M., Koshiol, J., Liu, H., Bergen, A.W., Rubagotti, M., Goldstein, A.M., Linnoila, I., Marincola, F.M., et al. (2010). MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res. 16, 430-441.
19. Lembo, A., Di Cunto, F., and Provero, P. (2012). Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer. PLoS One 7, e31129.
20. Li, M., Lee, K.F., Lu, Y., Clarke, I., Shih, D., Eberhart, C., Collins, V.P., Van Meter, T., Picard, D., Zhou, L., et al. (2009). Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. Cancer Cell 16, 533-546.
21. Li, D., Wang, Q., Liu, C., Duan, H., Zeng, X., Zhang, B., Li, X., Zhao, J., Tang, S., Li, Z., et al. (2012). Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation. Toxicol. Sci. 125, 382-391.
22. Lianoglou, S., Garg, V., Yang, J.L., Leslie, C.S., and Mayr, C. (2013). Ubiquitously transcribed genes use alternative polyadenylation to achieve tissuespecific expression. Genes Dev. 27, 2380-2396.
23. Liu, N., Cui, R.X., Sun, Y., Guo, R., Mao, Y.P., Tang, L.L., Jiang, W., Liu, X., Cheng, Y.K., He, Q.M., et al. (2014). A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int. J. Cancer 134, 1359-1368.
24. Mayo, L.D., Dixon, J.E., Durden, D.L., Tonks, N.K., and Donner, D.B. (2002). PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J. Biol. Chem. 277, 5484-5489.
25. Mayr, C., and Bartel, D.P. (2009). Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138, 673-684.
26. Miranda, K.C., Huynh, T., Tay, Y., Ang, Y.S., Tam, W.L., Thomson, A.M., Lim, B., and Rigoutsos, I. (2006). A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126, 1203-1217.
27. Nicoloso, M.S., Sun, H., Spizzo, R., Kim, H., Wickramasinghe, P., Shimizu, M., Wojcik, S.E., Ferdin, J., Kunej, T., Xiao, L., et al. (2010). Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 70, 2789-2798.
28. Ørom, U.A., Nielsen, F.C., and Lund, A.H. (2008). MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30, 460-471.
29. Özata, D.M., Caramuta, S., Velázquez-Fernández, D., Akçakaya, P., Xie, H., Höög, A., Zedenius, J., Bäckdahl, M., Larsson, C., and Lui, W.O. (2011). The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma. Endocr. Relat. Cancer 18, 643-655.
30. Puzio-Kuter, A.M., Castillo-Martin, M., Kinkade, C.W., Wang, X., Shen, T.H., Matos, T., Shen, M.M., Cordon-Cardo, C., and Abate-Shen, C. (2009). Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev. 23, 675-680.
31. Song, M.S., Salmena, L., and Pandolfi, P.P. (2012). The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296.
32. Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., and Mak, T.W. (2001). Regulation of PTEN transcription by p53. Mol. Cell 8, 317-325.
33. Tay, Y., Zhang, J., Thomson, A.M., Lim, B., and Rigoutsos, I. (2008). MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455, 1124-1128.
34. Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S.M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., et al. (2011). Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344-357.
35. Tay, Y., Song, S.J., and Pandolfi, P.P. (2013). The Lilliputians and the giant: an emerging oncogenic miRNA network that suppresses the PTEN tumor suppressor in vivo. MicroRNA 2, 127-136.
36. Tay, Y., Rinn, J., and Pandolfi, P.P. (2014). The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344-352.
37. Tsai, K.W., Kao, H.W., Chen, H.C., Chen, S.J., and Lin, W.C. (2009). Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells. Epigenetics 4, 587-592.
38. Vaira, V., Elli, F., Forno, I., Guarnieri, V., Verdelli, C., Ferrero, S., Scillitani, A., Vicentini, L., Cetani, F., Mantovani, G., et al. (2012). The microRNA cluster C19MC is deregulated in parathyroid tumours. J. Mol. Endocrinol. 49, 115-124.
39. Vlietstra, R.J., van Alewijk, D.C., Hermans, K.G., van Steenbrugge, G.J., and Trapman, J. (1998). Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res. 58, 2720-2723.
40. Vousden, K.H., and Lane, D.P. (2007). p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8, 275-283.
41. Zhang, H., Somasundaram, K., Peng, Y., Tian, H., Zhang, H., Bi, D., Weber, B.L., and El-Deiry, W.S. (1998). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16, 1713-1721.